Gene Correlation Network Analysis To Identify Regulatory Factors In Sciatic Nerve Injury

Abstract

Background: Sciatic nerve injury (SNI), which frequently occurs under the traumatic hip and hip fracture dislocation, induces serious complications such as motor and sensory loss, muscle atrophy, or even disabling. The present work aimed to determine the regulating factors and gene network related to the SNI pathology.Methods: Sciatic nerve injury dataset GSE18803 with 24 samples was randomly divided into adult group and neonate group. We performed weighted gene co-expression network analysis (WGCNA) to identify modules associated with SNI in the two groups. Moreover, differentially expressed genes (DEGs) were determined from every group, separately. Subsequently, co-expression network, protein-protein interaction (PPI) network, enrichment analysis and gene set enrichment analysis (GSEA) were integrated to identify hub genes and associated pathways. GSE30165 was used as the test set for investigating the hub gene involvement within SNI. Finally, we employed DGIdb for predicting the possible therapeutic agents leading to the abnormal up-regulation of hub genes.Results: 14 SNI status modules and 97 DEGs were identified in adult group, while 15 modules and 21 DEGs in neonate group. A total of 12 hub genes was overlapping from co-expression and PPI network. After the results from both test and training sets were overlapped, we verified that the ten real hub genes showed remarkably up-regulation within SNI. According to functional enrichment of DEGs, the above genes participated in the immune effector process, inflammatory responses, the antigen processing and presentation, and the phagocytosis. GSEA also supported that gene sets with the highest significance was mostly related to the cytokine-cytokine receptor interaction.Conclusions: The gene expression network is determined in the present work based on the related regulating factors within SNI, which sheds more lights on SNI pathology and offers the possible biomarkers and therapeutic targets in subsequent research.